RBP2 and cancer: Furthermore, our novel p57 results are also intriguing as decreased levels of p57 serve as a prognostic indicator for patient outcome in non-NET cancers.24 Given that our results demonstrate a direct regulation of p57 expression by RBP2, it is highly likely that RBP2 can also be used as a prognostic marker in NETs.